FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3157372178> ?p ?o ?g. }

• W3157372178 endingPage "3601" @default.
• W3157372178 startingPage "3586" @default.
• W3157372178 abstract "Breast cancer is among the leading causes of death due to cancers around the globe. Current therapeutic approaches towards healing of breast cancer have been associated with poor outcomes. Graphene and its derivatives have a two-dimensional flat structure, which is characterized by the ability to carry drugs and modify the surface, low cytotoxicity, and high biocompatibility. This study was performed on MCF7 and BT474 human breast cancer cells. Different concentrations of doxorubicin (DOX), graphene oxide (GO), and graphene oxide plus doxorubicin (GO-DOX) were subjected to both cell lines at specified intervals. At the end of the treatments, MTT test was applied to determine the viability of cells, and then flow cytometry, colony formation, and spheroid tests were implemented in both cell lines treated with DOX, GO, and GO-DOX components. We used DLS and TEM to confirm the GO properties. According to the MTT test results, 1 μL of DOX at 10 mg/ml (equivalent to 0.1 mg/ml) caused 50% survival of MCF7 cells at 24 h. In both cell lines, an increase in apoptosis occurred after incubation with GO and DOX. Although a rate of mortality of MCF-7 cells was due to necrosis, the BT474 cell death was merely through the apoptosis. Furthermore, the results of the colony formation test outlined an enhancing inhibitory effect in the presence of GO-DOX as a comparison to the control. Additionally, spheroids formed following treatment with GO-DOX exhibited a significant decrease compared to their control group, with an increase in the number of spheroids in BT474 cells compared to those in the MCF-7. The decreasing effect of compounds against the migration and cell invasion potential was also observed, being higher in MCF7 than BT474 cells. The effects of cytotoxic GO were observed at higher concentrations." @default.
• W3157372178 created "2021-05-10" @default.
• W3157372178 creator A5053063458 @default.
• W3157372178 creator A5075960314 @default.
• W3157372178 creator A5078181143 @default.
• W3157372178 date "2021-07-29" @default.
• W3157372178 modified "2023-09-25" @default.
• W3157372178 title "The Synergistic Anticancer Traits of Graphene Oxide Plus Doxorubicin Against BT474 and MCF7 Breast Cancer Stem Cells In Vitro" @default.
• W3157372178 cites W1494788738 @default.
• W3157372178 cites W1546117988 @default.
• W3157372178 cites W1978656850 @default.
• W3157372178 cites W1986688132 @default.
• W3157372178 cites W1991619674 @default.
• W3157372178 cites W1993656061 @default.
• W3157372178 cites W2003523044 @default.
• W3157372178 cites W2012588499 @default.
• W3157372178 cites W2020824171 @default.
• W3157372178 cites W2024594653 @default.
• W3157372178 cites W2033492289 @default.
• W3157372178 cites W2042182806 @default.
• W3157372178 cites W2056278562 @default.
• W3157372178 cites W2089642489 @default.
• W3157372178 cites W2093829713 @default.
• W3157372178 cites W2095510701 @default.
• W3157372178 cites W2104097924 @default.
• W3157372178 cites W2108251591 @default.
• W3157372178 cites W2121656289 @default.
• W3157372178 cites W2132998362 @default.
• W3157372178 cites W2294571275 @default.
• W3157372178 cites W2313142763 @default.
• W3157372178 cites W2316519017 @default.
• W3157372178 cites W2326842687 @default.
• W3157372178 cites W2467872404 @default.
• W3157372178 cites W2500669094 @default.
• W3157372178 cites W2511415621 @default.
• W3157372178 cites W2525707780 @default.
• W3157372178 cites W2560747312 @default.
• W3157372178 cites W2602935097 @default.
• W3157372178 cites W2616823805 @default.
• W3157372178 cites W2892376751 @default.
• W3157372178 cites W2901559248 @default.
• W3157372178 cites W2957984348 @default.
• W3157372178 doi "https://doi.org/10.1007/s12010-021-03623-8" @default.
• W3157372178 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34324153" @default.
• W3157372178 hasPublicationYear "2021" @default.
• W3157372178 type Work @default.
• W3157372178 sameAs 3157372178 @default.
• W3157372178 citedByCount "3" @default.
• W3157372178 countsByYear W31573721782022 @default.
• W3157372178 countsByYear W31573721782023 @default.
• W3157372178 crossrefType "journal-article" @default.
• W3157372178 hasAuthorship W3157372178A5053063458 @default.
• W3157372178 hasAuthorship W3157372178A5075960314 @default.
• W3157372178 hasAuthorship W3157372178A5078181143 @default.
• W3157372178 hasBestOaLocation W31573721782 @default.
• W3157372178 hasConcept C109316439 @default.
• W3157372178 hasConcept C121608353 @default.
• W3157372178 hasConcept C126322002 @default.
• W3157372178 hasConcept C178790620 @default.
• W3157372178 hasConcept C185592680 @default.
• W3157372178 hasConcept C190283241 @default.
• W3157372178 hasConcept C202751555 @default.
• W3157372178 hasConcept C203014093 @default.
• W3157372178 hasConcept C2776694085 @default.
• W3157372178 hasConcept C2777230088 @default.
• W3157372178 hasConcept C2780783641 @default.
• W3157372178 hasConcept C2781303535 @default.
• W3157372178 hasConcept C31573885 @default.
• W3157372178 hasConcept C502942594 @default.
• W3157372178 hasConcept C53227056 @default.
• W3157372178 hasConcept C54355233 @default.
• W3157372178 hasConcept C553184892 @default.
• W3157372178 hasConcept C55493867 @default.
• W3157372178 hasConcept C71924100 @default.
• W3157372178 hasConcept C81885089 @default.
• W3157372178 hasConcept C86803240 @default.
• W3157372178 hasConcept C96232424 @default.
• W3157372178 hasConcept C98274493 @default.
• W3157372178 hasConceptScore W3157372178C109316439 @default.
• W3157372178 hasConceptScore W3157372178C121608353 @default.
• W3157372178 hasConceptScore W3157372178C126322002 @default.
• W3157372178 hasConceptScore W3157372178C178790620 @default.
• W3157372178 hasConceptScore W3157372178C185592680 @default.
• W3157372178 hasConceptScore W3157372178C190283241 @default.
• W3157372178 hasConceptScore W3157372178C202751555 @default.
• W3157372178 hasConceptScore W3157372178C203014093 @default.
• W3157372178 hasConceptScore W3157372178C2776694085 @default.
• W3157372178 hasConceptScore W3157372178C2777230088 @default.
• W3157372178 hasConceptScore W3157372178C2780783641 @default.
• W3157372178 hasConceptScore W3157372178C2781303535 @default.
• W3157372178 hasConceptScore W3157372178C31573885 @default.
• W3157372178 hasConceptScore W3157372178C502942594 @default.
• W3157372178 hasConceptScore W3157372178C53227056 @default.
• W3157372178 hasConceptScore W3157372178C54355233 @default.
• W3157372178 hasConceptScore W3157372178C553184892 @default.
• W3157372178 hasConceptScore W3157372178C55493867 @default.
• W3157372178 hasConceptScore W3157372178C71924100 @default.
• W3157372178 hasConceptScore W3157372178C81885089 @default.

• next